Clinical Trial Update: TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

View source ↗

Summary

A clinical trial evaluating biomarkers for triple-negative breast cancer in liquid biopsies using artificial intelligence, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Jewish General Hospital | Conditions: Breast Cancer | Status: RECRUITING